AI-guided formulation development: Quotient Sciences and Intrepid Labs

Partnership integrates AI-driven formulation science with industry-leading Translational Pharmaceutics® platform, formulation and drug product expertise.

Leveraging advanced AI-driven formulation strategies, this collaboration empowers clients to:

Join us for our next webinar
 

Quickly identify the most effective composition for your drug product

Join us for our next webinar
 

Reduce API usage without compromising quality or performance

Join us for our next webinar
 

Transition new drug products into trials faster 

Andy Lewis, Chief Scientific Officer at Quotient Sciences:
"AI is opening new opportunities in drug development. With Intrepid’s technology, we can develop formulations and in silico models of their performance more rapidly."

AI-guided formulation with Translational Pharmaceutics®: A powerful model for drug development

Quotient Sciences Translational Pharmaceutics® has been trusted for nearly two decades and used globally by biotech and large pharma on over 500 programs with small molecule and peptide drug candidates. 

Together, Quotient Sciences and Intrepid Labs combine deep expertise with cutting-edge technology to transform formulation development into a streamlined, data-driven process.

Image
How does Translational Pharmaceutics work?